doi: 10.3389/fcdhc.2023.1293926 Received 13 September 2023 Accepted 16 November 2023 Published 08 December 2023 Volume 4 - 2023 Edited by Azra Durak-Nalbantic, Clinical Center University of Sarajevo, Bosnia and Herzegovina Reviewed by Edin Begic, Sarajevo School of Science and Technology, Bosnia and Herzegovina Updates Copyright 2023 Ferhatbegovi, Mri and Maci-Dankovi
10.1186/s13148-023-01575-w 152 WardR
Also, NOX could be activated through cSrc-dependent phosphorylation of p47phox, which is triggered by Ang II
Changes in eating patterns and caloric intake frequently accompany GLP-1 therapy, as these medications significantly reduce appetite and promote satiety
This information does NOT assure that this product is safe, effective, or appropriate for you